Cell & Gene Therapy

Support policy shaping and positioning in the gene therapy space, leveraging our expertise to drive impactful change and enhance client influence within the gene therapy ecosystem.

Address the unique challenges of evidence generation for gene therapies, such as demonstrating curative potential with short-term, low-volume trials, and develop compelling value propositions, leveraging in-depth market understanding, real-world evidence, and patient-centered insights to help clients articulate the unique benefits of their products.

Navigate challenges of pricing, reimbursement, and contracting for gene therapies, including payer hesitancy over high one-off costs and barriers to implementation of novel payment models, providing tailored strategies to support effective payer negotiation and achieve a value-maximizing pricing arrangement.

Support and optimize access and affordability of gene therapies, enabling clients to navigate complex market dynamics and implement effective strategies across geographies and market archetypes.

Provide comprehensive opportunity assessments leveraging deep market insights, regulatory expertise, and strategic analysis to help identify untapped potential, maximize value, and navigate the unique opportunities within the gene therapy landscape.

Guide the launch of gene therapies by adeptly strategizing, assessing readiness, and executing with precision, while equipping regional and local teams with essential activities to establish a strong foundation for successful market entry and sustained growth.

Provide expert support in medical and patient affairs, facilitating effective engagement with healthcare professionals and implementation of innovative strategies to identify and connect with patients in need.